Wanda Hunter

Regulatory Compliance Manager

Professional Overview

Wanda Hunter is an experienced Regulatory Compliance Manager with a strong background in the pharmaceutical industry. She leverages her expertise in regulatory compliance, quality assurance, and risk management to ensure Bristol-Myers Squibb's operations adhere to industry standards and legal requirements.

Experience Summary

Current Role

As the Regulatory Compliance Manager at Bristol-Myers Squibb in Princeton, New Jersey, Wanda is responsible for overseeing the company's compliance with all relevant regulations and guidelines. She develops and implements policies, procedures, and training programs to promote a culture of compliance across the organization. Wanda's keen attention to detail and proactive approach have been instrumental in identifying and mitigating potential compliance risks, contributing to the company's reputation for quality and integrity.

Career Progression

Prior to her current role, Wanda served as a Senior Compliance Specialist at Bristol-Myers Squibb, where she played a crucial role in establishing and maintaining robust compliance systems. Her strong analytical skills and commitment to continuous improvement have enabled her to drive process optimizations and enhance the overall compliance framework within the organization.

Academic Background

Wanda holds a degree in Biology/Biological Sciences, General from Rutgers University, where she developed a solid foundation in scientific principles and research methodologies.

Areas of Expertise

• Regulatory compliance management

• Quality assurance and control

• Risk assessment and mitigation

• Policy development and implementation

• Audit and inspection readiness

• Stakeholder engagement and training

Professional Impact

Wanda's contributions have been instrumental in ensuring Bristol-Myers Squibb's compliance with evolving regulatory requirements in the pharmaceutical industry. She has spearheaded the implementation of robust compliance monitoring systems, leading to the successful completion of numerous regulatory audits and inspections without any major findings. Wanda's proactive approach and collaborative leadership style have earned her the respect of her colleagues and industry peers.

Conclusion

With her extensive experience in regulatory compliance and a deep understanding of the pharmaceutical industry, Wanda Hunter is well-positioned to continue driving Bristol-Myers Squibb's commitment to ethical and compliant operations. Her dedication to excellence and her ability to navigate complex regulatory landscapes make her a valuable asset to the organization and a respected professional in the field.